AskAt Inc.

Organization

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-...
- Patent number 11,964,963
- Issue date Apr 23, 2024
- AskAt Inc.
- Yukari Inami
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 11,840,530
- Issue date Dec 12, 2023
- AskAt Inc.
- Yukinori Take
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the differential solubility-driven asymmetric transform...
- Patent number 11,555,023
- Issue date Jan 17, 2023
- AskAt Inc.
- Yoshiyuki Okumura
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EP4 inhibitors and use thereof
- Patent number 10,973,834
- Issue date Apr 13, 2021
- Arrys Therapeutics, Inc.
- Mark Manfredi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 10,947,235
- Issue date Mar 16, 2021
- AskAt Inc.
- Yukinori Take
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of EP4 receptor antagonists in the treatment of cartilage disease
- Patent number 10,786,490
- Issue date Sep 29, 2020
- AskAt Inc.
- Takako Okumura
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 10,611,761
- Issue date Apr 7, 2020
- AskAt Inc.
- Yukinori Take
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of EP4 receptor antagonists for the treatment of NASH-associate...
- Patent number 10,583,129
- Issue date Mar 10, 2020
- AskAt Inc.
- Naoko Ohtani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of EP4 receptor antagonists in the treatment of cartilage disease
- Patent number 10,391,086
- Issue date Aug 27, 2019
- AskAt Inc.
- Takako Okumura
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of EP4 receptor antagonists for the treatment of NASH-associate...
- Patent number 10,342,785
- Issue date Jul 9, 2019
- AskAt Inc.
- Naoko Ohtani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 9,688,674
- Issue date Jun 27, 2017
- AskAt Inc.
- Yukinori Take
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic agent for ocular disease
- Patent number 9,561,210
- Issue date Feb 7, 2017
- AskAt Inc.
- Takako Okumura
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salts and crystal forms
- Patent number 9,447,066
- Issue date Sep 20, 2016
- AskAt Inc.
- Yoshiyuki Okumura
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
STABLE SALT AND CRYSTAL FORMS OF 2-[3-({1-[2-(DIMETHYLAMINO)ETHYL]-...
- Publication number 20240352004
- Publication date Oct 24, 2024
- AskAt Inc.
- Yukari INAMI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EP4 INHIBITORS AND SYNTHESIS THEREOF
- Publication number 20240254120
- Publication date Aug 1, 2024
- Arrys Therapeutics, Inc.
- Mark MANFREDI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EP4 INHIBITORS AND USE THEREOF
- Publication number 20240066040
- Publication date Feb 29, 2024
- Arrys Therapeutics, Inc.
- Mark Manfredi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABLE SALT AND CRYSTAL FORMS OF 2-[3-({1-[2-(DIMETHYLAMINO)ETHYL]-...
- Publication number 20230322737
- Publication date Oct 12, 2023
- AskAt Inc.
- Yukari INAMI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR THE DIFFERENTIAL SOLUBILITY-DRIVEN ASYMMETRIC TRANSFORM...
- Publication number 20220144792
- Publication date May 12, 2022
- AskAt Inc.
- Yoshiyuki OKUMURA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20220073510
- Publication date Mar 10, 2022
- AskAt Inc.
- Yukinori TAKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GRAPIPRANT UNIT DOSAGE FORMS
- Publication number 20210353648
- Publication date Nov 18, 2021
- Arrys Therapeutics, Inc.
- Mark MANFREDI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EP4 INHIBITORS AND SYNTHESIS THEREOF
- Publication number 20210300921
- Publication date Sep 30, 2021
- Arrys Therapeutics, Inc.
- Mark MANFREDI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EP4 INHIBITORS AND USE THEREOF
- Publication number 20210290641
- Publication date Sep 23, 2021
- Arrys Therapeutics, Inc.
- Mark Manfredi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20200188367
- Publication date Jun 18, 2020
- AskAt Inc.
- Yukinori TAKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...
- Publication number 20190365680
- Publication date Dec 5, 2019
- AskAt Inc.
- Naoko OHTANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EP4 INHIBITORS AND USE THEREOF
- Publication number 20190314390
- Publication date Oct 17, 2019
- Arrys Therapeutics, Inc.
- Mark Manfredi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...
- Publication number 20190269663
- Publication date Sep 5, 2019
- AskAt Inc.
- Naoko OHTANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASE
- Publication number 20180193324
- Publication date Jul 12, 2018
- AskAt Inc.
- Takako OKUMURA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...
- Publication number 20180125832
- Publication date May 10, 2018
- AskAt Inc.
- Naoko OHTANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASE
- Publication number 20170360764
- Publication date Dec 21, 2017
- AskAt Inc.
- Takako OKUMURA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20170253595
- Publication date Sep 7, 2017
- AskAt Inc.
- Yukinori TAKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASE
- Publication number 20160317514
- Publication date Nov 3, 2016
- AskAt Inc.
- Takako OKUMURA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENT FOR OCULAR DISEASE
- Publication number 20160008317
- Publication date Jan 14, 2016
- AskAt Inc.
- Takako OKUMURA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALTS AND CRYSTAL FORMS
- Publication number 20150353520
- Publication date Dec 10, 2015
- AskAt Inc.
- Yoshiyuki OKUMURA
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
79161779 - ASKAT
- Serial number 79161779
- Registration number 4774905
- Filing date Sep 30, 2014
- AskAt Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
79161322
- Serial number 79161322
- Registration number 4834197
- Filing date Sep 30, 2014
- AskAt Inc.
- 42 - Scientific and technological services and research and design relating thereto

Organization

Patents Grantslast 30 patents

Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-...

Selective EP4 receptor antagonistic substance for treatment of cancer

Process for the differential solubility-driven asymmetric transform...

EP4 inhibitors and use thereof

Selective EP4 receptor antagonistic substance for treatment of cancer

Use of EP4 receptor antagonists in the treatment of cartilage disease

Selective EP4 receptor antagonistic substance for treatment of cancer

Use of EP4 receptor antagonists for the treatment of NASH-associate...

Use of EP4 receptor antagonists in the treatment of cartilage disease

Use of EP4 receptor antagonists for the treatment of NASH-associate...

Selective EP4 receptor antagonistic substance for treatment of cancer

Therapeutic agent for ocular disease

Salts and crystal forms

Patents Applicationslast 30 patents

STABLE SALT AND CRYSTAL FORMS OF 2-[3-({1-[2-(DIMETHYLAMINO)ETHYL]-...

EP4 INHIBITORS AND SYNTHESIS THEREOF

EP4 INHIBITORS AND USE THEREOF

STABLE SALT AND CRYSTAL FORMS OF 2-[3-({1-[2-(DIMETHYLAMINO)ETHYL]-...

PROCESS FOR THE DIFFERENTIAL SOLUBILITY-DRIVEN ASYMMETRIC TRANSFORM...

SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER

GRAPIPRANT UNIT DOSAGE FORMS

EP4 INHIBITORS AND SYNTHESIS THEREOF

EP4 INHIBITORS AND USE THEREOF

SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER

USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...

EP4 INHIBITORS AND USE THEREOF

USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...

USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASE

USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...

USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASE

SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER

USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASE

THERAPEUTIC AGENT FOR OCULAR DISEASE

SALTS AND CRYSTAL FORMS

Trademarklast 30 trademarks

79161779 - ASKAT

79161322